Akari Therapeutics, Plc announced that Melissa Bradford-Klug will step down as company's Chief Operating Officer effective May 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.71 USD | +19.87% |
|
+17.41% | +18.91% |
1st Jan change | Capi. | |
---|---|---|
+18.91% | 43.56M | |
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- AKTX Stock
- News Akari Therapeutics, Plc
- Melissa Bradford-Klug to Step Down as Chief Operating Officer of Akari Therapeutics, Plc